TEST

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others
Covid2
Loc RT-PCT Lab @ Purasawalkam
Loc No.935, P.H.Road, Purasawalkam,
 Chennai - 600084.
Loc (Next to Blue Diamond Hotel)
Loc 9345612448, 9345650993
Loc 9345662303, 9345709039
 Special On-Site services available for
 factories and Companies. Contact :
LocSenthil : 8825611543
LocYamini : 7397332352
LocGanesan : 9840950389

Test


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others

Note: Test Details are subject to change without any prior notice. Please confirm with the respective branches for current Details.
 
  A Top

Sno. Test Name Amount  Min Qty Ref. Value
1     a -Lactalbumin (f 76) - SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
2     A.S.O. TITRE 400   0.5 ml Adults : upto 200 IU/ml
Children : upto 150 IU/ml
3     A/G RATIO 120  
4     ABDOMEN - ERECT VIEW (XRAY) 300  
5     ABDOMEN (X -RAY) 300  
6     ABDOMEN SCAN 750  
7     ABSOLUTE B CELL COUNT 3500  
8     ABSOLUTE BASOPHIL COUNT 100   0.0 - 100 cells/cmm
9     ABSOLUTE EOSINOPHIL COUNT 100   1 ml 100 - 400 cells/cmm
10     ABSOLUTE LYMPHOCYTE COUNT 100   2 ml 1550 - 4000 cells/cmm.
11     ABSOLUTE MONOCYTE COUNT 100   0.0 - 700 cells/cmm
12     ABSOLUTE NEUTROPHIL COUNT 100   2 ml 2500 - 7000 Cells/cmm
13     ACE ( ANGIO TENSIN CONVERTING ENZYME) 1500   8 - 52 U/L
14     Acetyl Choline Receptor Antibodies 4000   Normal Levels : 0.0 to 0.39 nMol/L
Borderline Levels : 0.40 to 0.49 nMol/L
Positive levels : More than 0.50 nMol/L

Interpretation
Acetyl choline receptor antibody (AchR) helps to diagnose Myasthenia gravis. AchR antibodies are not found in congenital Myasthenia gravis.

Note: Laboratory reposts should not be interpreted in isolation. Always correlate with clinical and imaging data.
15     ACID PHOSPHATASE (PROSTATIC #) 500   1 ml 0 - 1.6 U/l
16     ACID PHOSPHATASE (TOTAL) 300   1 ml Men : 0 - 4.7 U/l
Women : 0 - 3.7 U/l
17     ACTH 1500   1 ml 7.2 - 63.3 pg/ml
18     ACTH STIMULATED 17 - OHP ( B) 900  
19     ACTH - PM 1250   UP TO 46.0 pg/ml.
20     ACTH STIMULATED 17 OHP 1200   Males : 0.5 - 2.1 ng/ml

Females

Follicular Phase : 0.1 - 0.8 ng/ml
Luteal Phase : 0.6 - 2.3 ng/ml
Ovulation : 0.3 - 1.4 ng/ml

Pregnancy

3rd Trimester : 2.0 - 12.0 ng/ml

CHILDREN (Girls)

1 month after birth : 2.4 - 16.8 ng/ml
2 month after birth : 1.6 - 9.7 ng/ml
3 month after birth : 0.1 - 3.1 ng/ml

CHILDREN (Boys)

1 month after birth : 0.0 - 8.0 ng/ml
2 month after birth : 3.6 - 13.7 ng/ml
3 month after birth : 1.7 - 4.0 ng/ml

Post ACTH: <3.2 ng/ml

Postmenopausal women: 0.13 - 0.51 ng/ml

21     ACTH STIMULATED CORTISOL 500  
22     Activated Protein - C Resistance(APC - R) 3000   1 ml More than 120 Seconds : Negative
Less than 120 Seconds : Positive
23     Active-B12 ( Holo Trans Cobalamin) 1250   Normal Adults :

35.1 to 165.0 pmol/L

Interpretation :
Less than 35 : Deficient
More than 35 : Not Deficient
24     ADENOSINE DEAMINASE (ADA) (ASCITIC FLUID) 750   2 ml Normal : 0-30 U/L

Positive : > 30 U/L

ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and
Malignancy.
25     ADENOSINE DEAMINASE (ADA) (ASPIRATION FLUID) 750  
26     ADENOSINE DEAMINASE (ADA) (PERICARDIAL FLUID) 750   2 ML Normal : < 30 U/L
Suspect : 30 - 40
Strong suspect : 40 - 60
Positive : > 60

ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and
Malignancy.
27     ADENOSINE DEAMINASE (ADA) (SYNOVIAL FLUID) 750  
28     ADENOSINE DEAMINASE (ADA)(BRONCHIAL WASH) 750  
29     ADENOSINE DEAMINASE (ADA)(CSF) 750   Normal : < 9 U/L
Positive : > 9 U/L

ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and
Malignancy.
30     ADENOSINE DEAMINASE (ADA)(PERITONEAL FLUID) 750  
31     ADENOSINE DEAMINASE (ADA)(PLEURAL FLUID) 750   Normal : 0-30 U/L

Positive : > 30 U/L

ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and
Malignancy.
32     ADENOSINE DEAMINASE (ADA)(SERUM) 750   2 mL Normal : 0-15 U/L
Positive : > 15 U/L

ADA Levels are raised in Tuberculosis, Infectious Mononucleosis,Viral Hepatitis and
Malignancy.
33     ADP 2000  
34     AFB STAIN 250  
35     AFB BACTEC ( MGIT) 460 - ISONIAZID (INH) 500  
36     AFB BACTEC 460 - AMIKACIN 750  
37     AFB BACTEC 460 - ETHAMBUTOL 750  
38     AFB BACTEC 460 (MGIT) - SIREP 3000  
39     AFB BACTEC 460 - CIPROFLOXACIN 750  
40     AFB BACTEC 460 - CYCLOSERINE 750  
41     AFB BACTEC 460 - ETHIONAMIDE 750  
42     AFB BACTEC 460 - KANAMYCIN 750  
43     AFB BACTEC 460 - OFLOXACIN 750  
44     AFB BACTEC 460 - PAS 750  
45     AFB BACTEC 460 - PYRAZINAMIDE 750  
46     AFB BACTEC 460 - RIFAMPICIN 750  
47     AFB BACTEC 460 - STREPTOMYCIN 750  
48     AFB BACTEC 460 -GENTAMICIN 750  
49     AFB BACTEC MGIT 320 - SIRE 3000  
50     AFB CULTURE by BACTEC ( MGIT)-Other Specimens 1000  
51     AFB CULTURE BY BACTEC( MGIT) Sputum 1000  
52     AFB STAIN (ASPIRATED FLUID) 250  
53     AFB STAIN (BRONCHIAL WASH) 200  
54     AFB STAIN (CSF) 200  
55     AFB STAIN (PERICARDIAL FLUID) 200  
56     AFB STAIN - CONCENTRATED METHOD 150  
57     AFP ( ASCITIC FLUID) 500   2 ML
58     AFP (ALPHA FETO PROTEINS) 600   1 ML Normal Adults : 0.89- 8.78 ng/ml

AFP (MATERNAL SERUM)
Cut off 2.5 MoM
15 weeks : upto 32.17 ng/ml 80.44
16 weeks : upto 36.86 ng/ml 92.16
17 weeks : upto 42.24 ng/ml 105.6
18 weeks : upto 48.4 ng/ml 120.99
19 weeks : upto 55.45 ng/ml 138.63
20 weeks : upto 63.53 ng/ml 158.84
21 weeks : upto 72.80 ng/ml 181.99

AFP Levels Increased in :
Cirrhosis Liver, Chronic Hepatitis,
Neural Tube defects, Germ cell Tumours,and
Hepatocellular carcinoma.(HCC)
59     AFP - (CSF) 500  
60     AFP - Tumour Marker 600   Reference Value : 0 to 7.0 ng/ml.

Increased in :
Cirrhosis Liver, Chronic Hepatitis,
Germ cell Tumours of the Ovary and Testis.
Very High levels are found in Hepatocellular Carcinoma.

61     ALBERT S STAIN 200  
62     ALBUMIN 100   0.5 ml Children
Upto 4days : 2.8 - 4.4 gm/dl
5 days -14 yrs : 3.8 - 5.4 gm/dl
15 Yrs -18 Yrs : 3.2 - 4.5 gm/dl

Adults : 3.5 - 5.2 gm/dl.


63     ALBUMIN (ASCITIC FLUID) 100  
64     ALBUMIN (CSF) 250   3 Months - 4 yrs : UPTO 45 mg/dl
More than 4 yrs : 10- 30 mg/dl
65     ALBUMIN (PLEURAL FLUID) 100  
66     ALCOHOL 200  
67     Aldolase 1150   Up to 7.40 U/L

Serum Aldolase determinations are useful in primary diseases of skeletal muscle.

Aldolase activity is useful in distinguishing neuromuscular atrophies from myopathies when used in conjunction with CK levels.

Serum Aldolase levels in the neonate is fourfold the adult activity and in children is twice that of adult values.

Aldolase levels are also elevated in cases of muscle injury, gangrene or infection. Strenuous exercise temporarily increases aldolase values.
68     ALDOSTERONE 1750   ADULTS

Supine : 30 -160 pg/ml
Upright : 70 -300 pg/ml

CHILDREN

AT BIRTH : 300-1900 pg/ml
1 Month to 2 Yrs : 20 - 1100 pg/ml
3 Years to 16 Yrs: 12 - 340 pg/ml
69     Alere - Cardiac Panel 1200  
70     Alere - D Dimer Test 900  
71     Alere - ProfilEr SOB Panel 2000  
72     Alere - Troponin I Test 750  
73     ALK / EML 4 (NSCLC) 8000  
74     ALKALINE PHOSPHATASE 150   0.5 ml Children Male(U/L) Female(U/L)
0 - 14 Days 83- 248 83-248
15 Days - 1 Yr 122- 469 122-469
1 Yr - 10 Yrs 142- 335 142-335
10 Yrs - < 13Yrs 129- 417 129-417
13 Yrs - < 15Yrs 116- 468 57-254
15 Yrs - < 17Yrs 82- 331 50-117
17 Yrs - < 19Yrs 55- 149 45-87

ADULT MALES : 40-129 U/L
ADULT FEMALES : 35-104 U/L
75     ALKAPTONURIA(URINE) 100  
76     ALL SPERM 0   >=40
77     Almond ( f 20)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
78     ALPHA 1 ANTI TRYPSIN 900   1 ML 90 - 200 mg/dl
79     Alpha Thalassemia MLPA 5500  
80     Alpha Thalassemia Mutation Analysis 6000  
81     Alternaria alternate (m6) - SPECIFIC IgE 600   1 ml Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
82     ALUMINIUM 1500   40 µg/L or less
83     AMA-M2,LKM-1,SLA/LP and LC1. 4500   SLA/LP., LKM-1,LC-1 and AMA -M2 are done together in a single strip. It is not possible to do any of these tests alone. The charges for a single test or all the tests are the same. Hence all tests will be done and reported.
84     Amino Acid (Quantitative) 5500  
85     Amino Acid ,Plasma 2250  
86     Amino Acid Disorders by TMS 2000  
87     AMINOACIDOGRAM 2200  
88     AML Multiplex PCR Panel 7500  
89     AMMONIA 600   Male : 16 - 60 µmol/L
Female : 11 - 51 µmol/L
90     Amoxicillin ( c 204)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
91     AMPHETAMINE (URINE) 200  
92     AMYLASE (CYSTIC FLUID) 400  
93     AMYLASE (URINE - 24 HOURS) 250   UPTO 1000 IU/L
94     AMYLASE -SERUM 400   1 ml 28-100 U/L
95     AMYLASE(ASCITIC FLUID) 400  
96     AMYLASE(PANCREATIC FLUID) 400  
97     AMYLASE(PERITONEAL FLUID) 400  
98     AMYLASE(PLEURAL FLUID) 400  
99     ANA / ENA EUROLINE 3000   1 ml
100     ANAEROBIC CULTURE 750  
101     ANCA 2000   1 ml
102     ANDROSTENEDIONE 1000   1 ml Females:
0 - 10 yrs : 0.02 - 0.86 ng/ml
11 - 17 yrs : 0.25 - 2.78 ng/ml
18 - 53 yrs : 0.75 - 3.89 ng/ml
54 - 82 yrs : 0.35 - 2.49 ng/ml

Males:
0 - 10 yrs : 0.01 - 1.31 ng/ml
11 - 17 yrs : 0.33 - 3.30 ng/ml
18 - 53 yrs : 0.45 - 4.20 ng/ml
54 - 82 yrs : 0.30 - 3.93 ng/ml
103     ANKLE JOINT AP/LAT (LEFT) 300  
104     ANKLE JOINT AP/LAT (RIGHT) 300  
105     ANKLE JOINT AP/LAT/OBLIQUE (BOTH) 600  
106     ANKLE JOINT AP/OBLIQUE (LEFT) 300  
107     ANKLE JOINT AP/OBLIQUE (RIGHT) 300  
108     ANTI - IA 2 Insulinoma Associated Antigen 5000   Less than 10.00 IU/mL

Note: Negative results do not exclude the diagnosis of or future risk for type 1 diabetes mellitus.The risk of developing type 1 diabetes may be stratified further by testing for:
1) Insulin antibodies
2) GAD antibodies
3) HLA genetic markers
109     ANTI - RNP 1000   Less than 1.0 : Negative
More than or equal to 1.0 TO 2.0: Weak Positive
More than or equal to 2.0 TO 5.0: Positive
More than or equal to 5.0 : High Positive
110     ANTI HB c (TOTAL) 600   1 ml
111     ANTI HBc IgM 600   1 ml
112     ANTI HBe 600   1 ml
113     ANTI HCV 750   1 ml Interpretation :

Sample RLU /Cut Off RLU
Less than 1.0 Non Reactive
More than 1.0 Reactive

Reactive samples must be confirmed by HCV RNA.

False Nonreactive results may occur during window period.Retesing should be done after 4 weeks.
114     ANTI HCV -ECLIA 600   1 ML
115     ANTI TB IGA (CSF) 300  
116     ANTI TB IGG(CSF) 300  
117     ANTI TB IGG(PLEURAL FLUID) 300  
118     ANTI TB IGM (CSF) 300  
119     ANTI TPO ANTIBODIES 750   0.5 ML 0.0 - 5.61 IU/ml.
120     ANTI - CCP 900   Less than 5.0 U/ml : Negative

>(or)Equal to 5.0 U/ml : Positive

Test methodology changed from CLIA to
CMIA. Please note the change in
reference interval.Result from
different manufacturer cannot be
used interchangeably.
121     ANTI CENTROMERE ANTIBODY 1000   1 ml Less than 1.0 : Negative
More than or equal to 1.0 TO 2.0: Weak Positive
More than or equal to 2.0 TO 5.0: Positive
More than or equal to 5.0 : High Positive
122     ANTI DNAse B (Anti Deoxyribo Nuclease B) 1500   Less than 200 U/ml

This assay is used for demonstration of acute or recent streptococcal infection. A number of bacterial antigens have been identified in cultures of group A streptococci. These are primarily enzymatic proteins and include streptolysin O, streptokinase, hyaluronidase, deoxyribonucleases (DNases A, B, C, and D), and nicotinamide adenine nucleotidase. Infections by the group A streptococci are unique because they can be followed by the serious nonpurulent complications of Rheumatic fever and Glomerulonephritis.
123     ANTI GAD ANTIBODIES 2500   LESS THAN 10 IU/ml : NEGATIVE

MORE THAN OR EQUAL TO 10 IU/mL: POSITIVE
124     Anti GBM Antibodies 1500   Reference Range :

Intensity Class Result

0 - 5 0 NEGATIVE
6 - 10 (+) BORDERLINE
11 - 25 + WEAK POSITIVE
26 - 50 ++ POSITIVE
> 50 +++ STRONG POSITVE


NOTE: RESULTS IN THE BORDERLINE RANGE FROM 6 - 10 SHOULD BE EVALUATED AS INCREASED BUT NEGATIVE. PLEASE
CORRELATE CLINICALLY
125     ANTI GBM ANTIBODY 1500   0.5 ml Reference Range :

Intensity Class Result

0 - 5 0 NEGATIVE
6 - 10 (+) BORDERLINE
11 - 25 + WEAK POSITIVE
26 - 50 ++ POSITIVE
> 50 +++ STRONG POSITVE


NOTE: RESULTS IN THE BORDERLINE RANGE FROM 6 - 10 SHOULD BE EVALUATED AS INCREASED BUT NEGATIVE. PLEASE
CORRELATE CLINICALLY
126     Anti Gliadin Ab IgG 1200  
127     Anti Gliadin IgA 1200  
128     ANTI HAV IgG 600   1 ml Less than 1.0 S/CO : Negative
More than 1.0 S/CO : Positive
129     ANTI HAV IgM 600   1 ml
130     ANTI HBs (QUANTITATIVE) 600   0.5 ml Less than 10 IU/l : No immunity
More than 10 IU/l : Acquired immunity

SUGGESTION FOR REVACCINATION :-
Anti HBs Level REVACCINATION
After Immunisation TO BE DONE
Less than 10 IU/l - Immediately.
10 - 100 IU/l - After 3 - 6 months.
100 - 1000 IU/l - After One year
1000 - 10000 IU/l - After 3 - 5 Years
More than 10000 IU/l - After 7 Years.
131     ANTI HEV IgM 750   1 ML
132     ANTI INSULIN ANTIBODY 3000   Less than 12 U/ml : Negative
12 - 18 U/ml : Equivocal
More than 18 U/ml : Positive

This is only a screening test for the diagnosis of IDDM (Type I Diabetes mellitus). It should be correlated with clinical history and results of other investigations.

NOTE :

1. Predicting the future development of Type 1 Diabetes in asymptomatic children, adolescents and adults when used in conjunction with family history, HLA typing & other autoantibodies
2. Differential diagnosis of Type 1 versus Type 2 Diabetes
3. Evaluating diabetics with insulin resistance
4. Investigation of hypoglycemia in non-diabetic subjects

133     ANTI LKM 1 ANTIBODIES 800  
134     ANTI MITOCHONDRIAL ANTIBODY 1000   0.5 ml
135     ANTI MULLERIAN HORMONE (AMH) 1350   Adult Females
20 - 24 yrs : 1.52 - 9.95 ng/ml
25 - 29 yrs : 1.20 - 9.05 ng/ml
30 - 34 yrs : 0.71 - 7.59 ng/ml
35 - 39 yrs : 0.40 - 6.96 ng/ml
40 - 44 yrs : 0.05 - 4.44 ng/ml
45 - 50 yrs : 0.01 - 1.79 ng/ml

PCOS Women : 2.41 - 17.1 ng/ml

Adult Males

1.43 -11.60 ng/ml
136     ANTI MUSK ANTIBODY 5000   LESS THAN 0.4 U/mL: NEGATIVE

MORE THAN 0.4 U/ml: POSITIVE

137     ANTI NUCLEAR AB ( ANA/ ANF - BY IFA ) 1000   0.5 ML
138     ANTI SMOOTH MUSCLE ANTIBODY 1000   1 ml
139     ANTI SPERM ANTIBODY 1200   0.5 ML Less than 150 mU/100ul: Negative

More than 150 mU/100ul: Positive
140     ANTI TB IGA 300   1 ml Less than 300 U/ml: Negative
300 - 600 U/ml: Low Positive
More than 600 U/ml: Positive
141     ANTI TB IGA (ASCITIC FLUID) 300  
142     ANTI TB IGG 300   1 ml Less than 400 U/ml : Negative
400 - 900 U/ml : Low Positive
More than 900 U/ml : Positive
143     ANTI TB IGG (ASCITIC FLUID) 300  
144     ANTI TB IGM 300   1 ml Less than 0.8 units : Negative
0.8 - 1.0 units : Equivocal
More than 1.0 units : Positive
145     ANTI TB IGM (ASCITIC FLUID) 300  
146     ANTI TSH RECEPTOR ANTIBODY 2500   2 Ml Upto 1.22 IU/L
147     Anti Xa, Heparin 6000   UFH Therapeutic Range : 0.30-0.70 IU/mL

LMWH Therapeutic Ranges (target anti-Xa levels measured 4 hours after dosing):

Enoxaparin (Lovenox)
Therapeutic bid dosing : 0.6-1.0 IU/mL
Therapeutic qD dosing : >1.0 IU/mL
Tinzaparin (Innohep)
Therapeutic qD : 0.85 IU/mL
Dalteparin (Fragmin)
Therapeutic qD : 1.05 IU/mL

Reference : Chest 2012;141;e24s-e43s
148     Antidiuretic Hormone(ADH) 3500   30 - 150 pg/ml
149     ANTITHROMBIN III 1250   0.5 ML 80 - 120 %
150     APC-R ( Activated Protein C Resitance) 4000   1 ml Clotting time of More than 120 Seconds reported as Negative , and less than 120 seconds reported as Positive. No time in seconds will be given in the report.

APC-R positive patients may be referred for Factor V Leiden ( FVL) mutation Analysis to find out the Genotype.
151     APO LIPOPROTEIN A1 400   0.5 ml 12 - 19 Yrs Male : 99 - 165 mg/dl
12 - 19 Yrs Female: 105 - 180 mg/dl
Normal risk Male : 104 - 202 mg/dl
Normal risk Female: 108 - 225 mg/dl
Favourable Male : > 202 mg/dl
Favourable Female : > 225 mg/dl
High Risk : < 104 mg/dl
152     APO LIPOPROTEIN E 500   3 - 6 mg/dl
153     APO LIPOPROTEIN B 400   0.5 ml 12 - 19 Yrs Male : 55 - 110 mg/dl
12 - 19 Yrs Female: 53 - 119 mg/dl
Normal risk Male : 66 - 133 mg/dl
Normal risk Female: 60 - 117 mg/dl
High Risk Male : > 133 mg/dl
High Risk Female : > 117 mg/dl
Favourable : < 51 mg/dl




154     APPENDIX 500  
155     Apple (f49) - SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
156     APTT -Stago 250   Reference Range : 27 to 35 Seconds
157     Aquaporin & MOG ( Myeline Oligodendrocyte) 5000  
158     Aquaporin & MOG ( Myeline Oligodendrocyte) CSF 5000  
159     Aquaporin 4 Abs ( NMO Antibodies) 4000  
160     Aquaporin 4 Abs( NMO Antibodies) -CSF 3000   1.5 ML CSF
161     ARSENIC 2000   0.4 - 11.9 ug/L
162     ASCA - IgA (Saccharomyces Ab IgA) 1250   1 mL LESS THAN 12 U/ml: NEGATIVE
12 - 18 U/mL : EQUIVOCAL
MORE THAN 18 U/mL: POSITIVE
163     ASCA - IgG (Saccharomyces Ab IgG) 1250   1 ml LESS THAN 12 U/ml: NEGATIVE
12 - 18 U/mL : EQUIVOCAL
MORE THAN 18 U/mL: POSITIVE
164     Aspergillosis Ab IgG - Serum 2000   Interpretation
--------------
< 8.00 U/mL : Negative
8 - 12 U/mL : Equivocal
> 12.00 U/mL : Positive

Aspergillus organism has the ability to produce a wide spectrum of infections including Mycotoxicosis, allergic manifestations, localized non-invasive infection in normal host and invasive infection in the compromised host.
Aspergillus fumigatus is the most common species associated with human diseases followed by Aspergillus flavus.
Lung Aspergillosis includes Primary pulmonary aspergillosis, Acute invasive pulmonary disease, Aspergillus pseudotuberculosis, Chronic necrotizing pulmonary aspergillosis and Aspergilloma.

All positive results should be confirmed by microbiologic and clinical evaluation.

False positive results are commonly seen in children and in patients on antimicrobial therapy like Piperacillin -Tazobactum and Amoxicillin-Clavulanate.


165     Aspergillosis amstelodami(m17) - SPECIFIC IgE 600   Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
166     Aspergillosis fumigatus(m3) - SPECIFIC IgE 600   1 ml Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
167     Aspergillus niger(m33) - SPECIFIC IgE 600   Less than 0.35 IU/mL: Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL: Very High Positive
168     Aspirin ( c 51)- SPECIFIC IgE 600   Less than 0.35 IU/mL : Negative
0.36 - 0.70 IU/mL : Low Positive
0.71 - 3.50 IU/mL : Moderate Positive
3.51 - 17.50 IU/mL : High Positive
More than 17.50 IU/mL : Very High Positive
169     Aspirin - Clopidogrel Resistance Test 3000   Interpretation :
Clopidogrel Resistance Test:
More than 46 : Resistance present. High Thrombotic Risk
31-19 : High Bleeding Risk
Less than 19 : Very High Bleeding Risk. Dose may be reduced.

Aspirin Resistance Test:
71- 115 : Resistance present
Less than 40 : Inhibition of COX-1 by Aspirin. No resistance.
Less than 30 : Strong inhibition of COX-1 by Aspirin. Dose may be reduced.

170     AUDIOMETRY 300  
171     Autoimmune Encephalitis Panel(NMDA,AMPA,GABA,LG1,C 15000  
 
 
 
  Ā© Copyrights 2009 HITECH DIAGNOSTIC CENTRE. All rights reserved   | About Us| Sitemap